HUP0002236A3 - Solubilized sertraline compositions and process for their preparation - Google Patents

Solubilized sertraline compositions and process for their preparation

Info

Publication number
HUP0002236A3
HUP0002236A3 HU0002236A HUP0002236A HUP0002236A3 HU P0002236 A3 HUP0002236 A3 HU P0002236A3 HU 0002236 A HU0002236 A HU 0002236A HU P0002236 A HUP0002236 A HU P0002236A HU P0002236 A3 HUP0002236 A3 HU P0002236A3
Authority
HU
Hungary
Prior art keywords
preparation
compositions
solubilized
solubilized sertraline
sertraline compositions
Prior art date
Application number
HU0002236A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0002236(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HUP0002236A2 publication Critical patent/HUP0002236A2/hu
Publication of HUP0002236A3 publication Critical patent/HUP0002236A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0002236A 1997-07-01 1998-06-15 Solubilized sertraline compositions and process for their preparation HUP0002236A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
HUP0002236A2 HUP0002236A2 (hu) 2003-08-28
HUP0002236A3 true HUP0002236A3 (en) 2003-12-29

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002236A HUP0002236A3 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions and process for their preparation

Country Status (34)

Country Link
EP (1) EP0999829A1 (tr)
JP (1) JP2000514100A (tr)
KR (1) KR100366373B1 (tr)
CN (1) CN1261794A (tr)
AP (1) AP1192A (tr)
AR (3) AR015917A1 (tr)
AU (1) AU742535B2 (tr)
BG (1) BG103918A (tr)
BR (1) BR9810739A (tr)
CA (1) CA2290974C (tr)
CO (1) CO4940495A1 (tr)
DZ (1) DZ2548A1 (tr)
EA (1) EA002481B1 (tr)
HN (1) HN1998000102A (tr)
HR (1) HRP980377A2 (tr)
HU (1) HUP0002236A3 (tr)
ID (1) ID23429A (tr)
IL (1) IL133076A (tr)
IS (1) IS5260A (tr)
MA (1) MA24587A1 (tr)
NO (1) NO996520L (tr)
OA (1) OA11243A (tr)
PA (1) PA8454301A1 (tr)
PE (1) PE97199A1 (tr)
PL (1) PL337804A1 (tr)
SK (1) SK181099A3 (tr)
TN (1) TNSN98124A1 (tr)
TR (1) TR199903297T2 (tr)
TW (1) TW550087B (tr)
UA (1) UA67741C2 (tr)
UY (1) UY25071A1 (tr)
WO (1) WO1999001120A1 (tr)
YU (1) YU68299A (tr)
ZA (1) ZA985708B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EA199900962A1 (ru) 2000-08-28
YU68299A (sh) 2002-06-19
AR015917A1 (es) 2001-05-30
OA11243A (en) 2003-07-24
PE97199A1 (es) 1999-10-05
HUP0002236A2 (hu) 2003-08-28
SK181099A3 (en) 2000-07-11
TW550087B (en) 2003-09-01
CA2290974A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
AU7544898A (en) 1999-01-25
BG103918A (en) 2000-07-31
CA2290974C (en) 2004-04-27
CN1261794A (zh) 2000-08-02
TR199903297T2 (tr) 2000-07-21
CO4940495A1 (es) 2000-07-24
KR20010013365A (ko) 2001-02-26
AU742535B2 (en) 2002-01-03
NO996520D0 (no) 1999-12-28
IL133076A (en) 2003-12-10
DZ2548A1 (fr) 2003-02-08
HRP980377A2 (en) 1999-04-30
AP1192A (en) 2003-07-23
EP0999829A1 (en) 2000-05-17
KR100366373B1 (ko) 2003-01-14
UY25071A1 (es) 2000-12-29
PL337804A1 (en) 2000-09-11
ID23429A (id) 2000-04-20
IL133076A0 (en) 2001-03-19
UA67741C2 (uk) 2004-07-15
AR040279A2 (es) 2005-03-23
MA24587A1 (fr) 1998-12-31
WO1999001120A1 (en) 1999-01-14
PA8454301A1 (es) 2000-09-29
HN1998000102A (es) 1999-01-08
JP2000514100A (ja) 2000-10-24
NO996520L (no) 2000-02-29
IS5260A (is) 1999-11-19
TNSN98124A1 (fr) 2005-03-15
AR040280A2 (es) 2005-03-23
BR9810739A (pt) 2000-09-12
EA002481B1 (ru) 2002-06-27
ZA985708B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
ZA985180B (en) 4-Haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines process for their preparation compositions comprising them and their use as pesticides
HK1002682A1 (en) Solid lipophilic composition and process for its preparation
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
AP9901444A0 (en) Erythrommycins and process for their preparation
IL124350A (en) Resorcinyl-triazines, a process for their preparation and cosmetic compositions comprising them
GB9406555D0 (en) Shampoo composition
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
GB9415421D0 (en) Cosmetic compositions and processes for manufacture thereof
HUP0000733A3 (en) Aminoguanidines and alkoxyguanidines as and pharmaceutical compositions containing them
HUP0000426A3 (en) Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation
BG105437A (en) REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
GB2327190B (en) Process for the preparation of depilatory compositions and their use
IL133997A (en) 2-[pyrazolyl- and triazolyl-3'-oxymethylene] phenylisoxazolones, -triazolones and -tetrazolones, their preparation and compositions comprising them
IL128018A0 (en) Synthetic polysaccharides preparation method therefor and pharmaceutical compositions containing same
HUP0104985A3 (en) Pharmaceutical levothyroxine compositions and process for their preparation
IL116015A0 (en) Iminooxymethyleneanilides thdir preparation and compositions containing them
ZA986520B (en) Coating composition and process for its preparation
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
HUT75112A (en) Oxathiolanes, method for their preparation and pharmaceutical compositions contating same
HUP0002236A3 (en) Solubilized sertraline compositions and process for their preparation
GB9415420D0 (en) Cosmetic compositions and processes for manufacture thereof
HUP0101822A3 (en) Effervescent compositions and process for their preparation
GB9814869D0 (en) Process and composition

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees